Stephen D. Wolpe
32Patents
6h-index
19Co-inventors
66Inventor score
Filing activity: Mar 7, 1994 → Feb 16, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5698419A | Monoclonal antibodies to cachectin/tumor necrosis factor and methods for preparing same | Physics | 49 | Expired |
| US5861483A | Inhibitor of stem cell proliferation and uses thereof | Human Necessities | 20 | Expired |
| US5616688A | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5700466A | Method of ameliorating or preventing septic shock using a monoclonal antibody specific to cachectin/tumor necrosis factor | Physics | 9 | Expired |
| US5939391A | Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation | Electricity | 8 | Expired |
| US7514555B2 | Compounds for the treatment of metabolic disorders | Human Necessities | 8 | Expired |
| US7851494B2 | Method for the treatment of metabolic disorders | Chemistry; Metallurgy | 5 | Active |
| US8178675B2 | Compounds for the treatment of metabolic disorders | Human Necessities | 5 | Active |
| US6090782A | Hemoglobin alpha and beta chain peptide fragments useful for inhibiting stem cell proliferation | Electricity | 5 | Expired |
| US5703206A | Macrophage inflammatory protein 2 (MIP-2) | Physics | 5 | Expired |
| US7115267B2 | Stimulator of stem cell division | Human Necessities | 5 | Expired |
| US6019969A | Composition comprising antibody to macrophage-derived inflammatory mediator (MIP-.alpha. 1 and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7645772B2 | Treatment of metabolic disorders | Human Necessities | 3 | Expired |
| US5817763A | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5650147A | Methods of stimulating granulocyte-macrophage progenitor cells | Physics | 3 | Expired |
| US6784155B1 | Inhibitor and stimulator of stem cell proliferation and uses thereof | Human Necessities | 3 | Expired |
| US6046309A | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5760186A | Antibody to macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5849873A | Macrophage-derived inflammatory mediator (MIP-1 .alpha. and MIP-1 .beta.) | Physics | 2 | Expired |
| US5863535A | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5942222A | Methods of treating granulocyte-macrophage progenitor cell-derived blood cell dysfunction | Physics | 2 | Expired |
| US5741484A | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Physics | 2 | Expired |
| US5989836A | Method for measuring the binding sites for macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 2 | Expired |
| US10030015B2 | Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity | Emerging Cross-Sectional Technologies | 2 | Active |
| US7973052B2 | Compounds for the treatment of metabolic disorders | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.